Gabriel Malouf: 2025 Cancer Research Prize of the Simone and Cino Del Duca Foundation – Institut de France

The Academy of Sciences highlighted the major impact of his research, which has revolutionized the understanding of several rare cancers.

Using cutting-edge multi-omic approaches, Gabriel Malouf has identified key biomarkers and characterized molecular subtypes of rare tumors, such as those of the kidney, liver, and sinuses. His work has also uncovered mechanisms of treatment resistance, paving the way for innovative therapeutic strategies.

The award ceremony took place on November 25, 2025, under the Dome of the Institut de France.

Founded in 1975 and affiliated with the Institut de France since 2005, the Simone and Cino Del Duca Foundation continues the vision of its founder: supporting research and promoting scientific excellence.

Excerpt from the award presentation by Antoine Triller, Permanent Secretary of the Academy of Sciences:

"The Cancer Research Prize of the Simone and Cino Del Duca Foundation was created in 1985 and is intended for a scientist under 45, of any nationality, working in France, whose discoveries have led to a significant advancement in our understanding of the cellular mechanisms leading to tumor transformation. Gabriel Malouf, professor at the University of Strasbourg, at the Institute of Genetics and Molecular and Cellular Biology, is a hospital practitioner at the University Hospital of Strasbourg and leads a translational oncology research team at IGBMC. He explores and dissects omic alterations and molecular mechanisms involved in the development of kidney cancers and rare tumors, as well as their treatment resistance, in order to connect fundamental and clinical research and to design innovative personalized medicine strategies.
Congratulations Gabriel Malouf!"